MARASCO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 2.297
EU - Europa 1.359
AS - Asia 498
AF - Africa 30
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 4.188
Nazione #
US - Stati Uniti d'America 2.231
IT - Italia 588
CN - Cina 399
NL - Olanda 171
IE - Irlanda 150
FI - Finlandia 135
DE - Germania 102
UA - Ucraina 88
GB - Regno Unito 67
CA - Canada 65
IN - India 43
SE - Svezia 32
CI - Costa d'Avorio 30
VN - Vietnam 30
FR - Francia 12
SG - Singapore 10
IR - Iran 6
ES - Italia 5
HK - Hong Kong 5
AU - Australia 2
CZ - Repubblica Ceca 2
JP - Giappone 2
PK - Pakistan 2
PL - Polonia 2
PT - Portogallo 2
AT - Austria 1
CH - Svizzera 1
DK - Danimarca 1
DM - Dominica 1
EU - Europa 1
QA - Qatar 1
VE - Venezuela 1
Totale 4.188
Città #
Chandler 541
Naples 197
Millbury 173
Amsterdam 166
Princeton 141
Nanjing 129
Beijing 92
Boston 92
Jacksonville 91
Ashburn 85
Napoli 83
Ottawa 61
Des Moines 60
Wilmington 47
Nanchang 39
Dong Ket 30
Hebei 28
Lawrence 27
Houston 26
Norwalk 20
Casapulla 19
Jiaxing 19
Pune 19
Shenyang 18
Tianjin 18
Munich 15
Changsha 14
Kronberg 14
Ann Arbor 13
Woodbridge 13
Rome 12
Padova 10
Dublin 8
Falls Church 8
Milan 8
Boardman 7
Fairfield 7
Seattle 7
Singapore 7
Augusta 6
Orange 6
Redmond 6
Redwood City 6
Indiana 5
Los Angeles 5
Salerno 5
Taizhou 5
Berlin 4
Caserta 4
Changchun 4
Kunming 4
Leawood 4
Nijmegen 4
Ningbo 4
Potenza 4
Roorkee 4
Boscoreale 3
Cardito 3
Florence 3
Guangzhou 3
Hangzhou 3
Jenera 3
Jinan 3
Madrid 3
Marano Di Napoli 3
San Mateo 3
Shanghai 3
Somma Vesuviana 3
Washington 3
Acquappesa 2
Ardabil 2
Arezzo 2
Bari 2
Baronissi 2
Delhi 2
Frankfurt am Main 2
Genova 2
Giugliano In Campania 2
Halethorpe 2
Hong Kong 2
Karachi 2
Kumar 2
Lanzhou 2
Lappeenranta 2
Limeil-brévannes 2
Lisbon 2
London 2
Mountain View 2
Palese 2
Piaggine 2
Pozzuoli 2
Reutlingen 2
Romainville 2
Sannicandro Garganico 2
Stockholm 2
Toronto 2
Trieste 2
Urbino 2
West Lafayette 2
Xian 2
Totale 2.545
Nome #
Endocannabinoid System in Neurological Disorders 66
The acute myeloid leukemia-associated Nucleophosmin 1 gene mutations dictate amyloidogenicity of the C-terminal domain 63
Amyloid fibers deriving from the aromatic core of C-terminal domain of nucleophosmin 1 61
SYNTHESIS AND STRUCTURAL STUDIES OF CRIPTO PROTEIN FUNCTIONAL DOMAINS 58
Nucleophosmin-1 regions associated with acute myeloid leukemia interact differently with lipid membranes 58
Diolein based nanostructures for theranostic applications 55
Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15 52
Improved Fmoc SPPS by chain protonation and in situ neutralization 50
Evaluating the biological properties of synthetic 4-nitrophenyl functionalized benzofuran derivatives with telomeric DNA binding and antiproliferative activities 50
Conformational and Coordination Properties of a Peptide Containing α,α-di(2-Pyridyl)Glicine, a Linker for Supramolecular Assembly of Proteins 49
BMP-2 fragments: synthesis, structural characterization, binding properties and biological activity 49
Structural insights into amyloid structures of the C-terminal region of nucleophosmin 1 in type A mutation of acute myeloid leukemia 47
Effects of surface nanopatterning on internalization and amyloid aggregation of the fragment 264-277 of Nucleophosmin 1 45
Ab(25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity. 44
An artificial hemoprotein: mimochrome IV 44
A Conformational analysis of Cripto CFC domain 43
Sistemi Modello di Metalloenzimi 43
Synthetic and structural routes for the rational conversion of peptides into small molecules 42
Evaluation of an Analogue of the Marine ε-PLL Peptide as a Ligand of G-quadruplex DNA Structures 42
A comparative study of the effects of platinum (Ii) complexes on β-amyloid aggregation: Potential neurodrug applications 42
The solution structure of mouse Cripto CFC domain and of its inactive variant Trp107Ala 41
A new ligand for immunoglobulin G subdomains by screening of a synthetic peptide library 41
In Silico Generation of Peptides by Replica Exchange Monte Carlo: Docking-Based Optimization of Maltose-Binding-Protein Ligands 41
SOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytes 41
Biotic and environmental stress induces nitration and changes in structure and function of the sea urchin major yolk protein toposome 40
Diolein based nanostructures as targeted theranostics 39
Peptide antagonists of the PED-hPLD1 binding 39
The human prion protein alpha2 helix: a thermodynamic study of its conformational preferences 38
De Novo Designed Four Helix Bundles as Models of Functional Proteins 38
Design and analysis of EphA2-SAM peptide ligands: A multi-disciplinary screening approach 38
Destabilisation, aggregation, toxicity and cytosolic mislocalisation of nucleophosmin regions associated with acute myeloid leukemia 37
Characterization of linear mimetic peptides of Interleukin-22 from dissection of protein interfaces 36
Crystallization and preliminary X-ray crystallographic analysis of two dimeric hyperthermostable thioredoxins isolated from Sulfolobus solfataricus. 35
A structural insight into the Nodal-Cripto binding 35
Mapping the protein-binding sites for iridium(III)-based CO-releasing molecules 35
Glucosyl Platinum(II) Complexes Inhibit Aggregation of the C-Terminal Region of the Aβ Peptide 35
Chemical synthesis of mouse Cripto CFC variants. 34
PRION PROTEINS’ CONFORMATIONAL CONVERSION: ROLE OF THE SYNTHETIC PRP 178-193 FIBRILLOGENIC PEPTIDE 34
Effect of Salts on the Structural Behavior of hPrP 2-Helix-Derived Analogues 34
G-quadruplex DNA recognition by nucleophosmin: New insights from protein dissection 34
Nucleophosmin contains amyloidogenic regions that are able to form toxic aggregates under physiological conditions 34
Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties 34
Mimetics of suppressor of cytokine signaling 3: Novel potential therapeutics in triple breast cancer 34
Exploring the ability of cyclic peptides to target SAM domains: a computational and experimental study 34
Structural and functional insights into IκB-α/HIV-1 Tat interaction. 33
Design of a new mimochrome with unique topology 32
Cell recruitment and transfection in gene activated collagen matrix 32
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces 32
Structure-activity studies of peptidomimetics based on kinase-inhibitory region of suppressors of cytokine signaling 1 32
Miniaturized Metalloproteins: Application to Iron-Sulfur Proteins 31
Selective disruption of insulin-like growth factor-1 (IGF-1) signaling via phosphoinositide-dependent kinase-1 prevents the protective effect of IGF-1 on human cancer cell death. 31
Structural and binding properties of the PASTA domain of PonA2, a key penicillin binding protein from Mycobacterium tuberculosis 31
Identification of inhibitors of biological interactions involving intrinsically disordered proteins 31
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response 31
Platinum(II) O,S Complexes Inhibit the Aggregation of Amyloid Model Systems 31
Structural investigations on the Nodal-Cripto binding: a theoretical and experimental approach 30
Chemical Basis of Peptidoglycan Discrimination by PrkC, a Key Kinase Involved in Bacterial Resuscitation from Dormancy. 30
CD and NMR conformational studies of a peptide encompassing the Mid Loop interface of Ship2-Sam 30
Peptide Fragments of Odin-Sam1: Conformational Analysis and Interaction Studies with EphA2-Sam 30
Covalently immobilized RGD gradient on PEG hydrogel scaffold influences cell migration parameters 29
Miniaturized Iron-Sulfur Proteins 29
Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers 29
Osteogenic properties of a short BMP-2 chimera peptide 29
Dependence of cell migration parameters on steepness of RGD gradient slope 29
Insights into amyloid-like aggregation of H2 region of the C-terminal domain of nucleophosmin 29
Nasal and systemic eosinophilia associated with solid intestinal tumors, a case report and review of the literature. 29
Modulation of amyloidogenic peptide aggregation by photoactivatable co-releasing ruthenium(II) complexes 29
The dimeric structure of Sulfolobus solfataricus thioredoxin A2 and the basis of its thermostability. 28
Design, Synthesis and Spectroscopic Characterization of Miniaturized Hemoproteins 28
Structural investigation of a C-terminal EphA2 receptor mutant: Does mutation affect the structure and interaction properties of the Sam domain? 28
The chemical synthesis of the GstI protein by NCL on a x-met site. 27
A peptide from the N-terminal region of PED/PEA-15 blocks its interaction with PLD1 and restores insulin sensitivity in skeletal muscle cells 27
NMR Structural Study of CFC Cripto domain 27
Dependence of cell migration on covalently immobilized RGD gradients in PEGDA-Based hydrogels 27
Identification and characterization of nasal polyposis and mycoplasma superinfection by scanning electron microscopy and nasal cytology with optical microscopy: A case report 27
Does tetracycline bind helix 2 of prion? An integrated spectroscopical and computational study of the interaction between the antibiotic and alpha helix 2 human prion protein fragments. 26
Targeting "Undruggable" Proteins: Design of Synthetic Cyclopeptides 26
The Sam-Sam interaction between Ship2 and the EphA2 receptor: Design and analysis of peptide inhibitors 26
Engineered β-hairpin scaffolds from human prion protein regions: Structural and functional investigations of aggregates 26
Amino acid transport in thermophiles: characterization of an arginine-binding protein in Thermotoga maritima 25
X-ray structural studies of the entire extracellular region of the serine/threonine kinase PrkC from Staphylococcus aureus 25
Anti-allergic properties of a new all-D synthetic immunoglobulin-binding peptide 25
Human AP-endonuclease (Ape1) activity on telomeric G4 structures is modulated by acetylatable lysine residues in the N-terminal sequence 25
Peptides as therapeutic agents for inflammatory-related diseases 25
Residues 762-801 of PLD1 mediate the interaction with PED/PEA15 25
Miniaturized Proteins: Application to the Design of metallo-protein models 24
Sam domain-based stapled peptides: Structural analysis and interaction studies with the Sam domains from the EphA2 receptor and the lipid phosphatase Ship2 24
Role of the Metal Center in the Modulation of the Aggregation Process of Amyloid Model Systems by Square Planar Complexes Bearing 2-(2'-pyridyl)benzimidazole Ligands 24
Miniaturized Metalloproteins 23
Lead Optimization of P5U and Urantide: Discovery of Novel Potent Ligands at the Urotensin-II Receptor 23
Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade 23
Self-assembly of bio-inspired heterochiral peptides 23
Insights on the interaction between human Cripto and its receptors. 22
Integration of binding peptide selection and multifunctional particles as tool-box for capture of soluble proteins in serum 22
Structural insights into the interaction between the Cripto CFC domain and the ALK4 receptor 21
A small synthetic cripto blocking Peptide improves neural induction, dopaminergic differentiation, and functional integration of mouse embryonic stem cells in a rat model of Parkinson's disease 21
Heparin-binding hemagglutinin HBHA from Mycobacterium tuberculosis affects actin polymerisation 21
Conformational consequences of NPM1 rare mutations: An aggregation perspective in Acute Myeloid Leukemia 21
Miniaturized Hemoproteins 20
Mitochondria Targeting with Luminescent Rhenium(I) Complexes 20
Totale 3.388
Categoria #
all - tutte 19.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.765


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201944 0 0 0 0 0 0 0 0 0 0 10 34
2019/2020524 236 6 31 21 36 2 2 1 11 48 82 48
2020/2021380 10 23 29 25 54 61 28 14 56 6 43 31
2021/2022971 11 2 12 12 31 16 12 22 165 128 164 396
2022/20231.319 182 115 29 110 174 140 3 128 212 162 53 11
2023/2024676 53 150 196 43 30 79 23 54 22 25 1 0
Totale 4.521